Ali Choucair - Concepedia

Author

Ali Choucair

The University of Texas MD Anderson Cancer Center

Also Known As

A Choucair, A K Choucair, A. Choucair, A. K. CHOUCAIR, A. K. Choucair, A.K. Choucair, Ali Choucair, Ali K Choucair, Ali K. Choucair, AliK Choucair

Publications

4.3K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center RTOG Foundation University of California, San Francisco McGill University Emory University

About

Ali Choucair is an author at The University of Texas MD Anderson Cancer Center specializing in neuro-oncology, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	959
2	Health Sciences	9	9	833
3	Neurology	7	7	479
4	Social Sciences	1	1	39
5	Diagnostic Sciences	1	1	20

Ali Choucair

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial Paul D. Brown, S. Pugh, Nadia N. Laack, Neuro-Oncology	2013	921
Development of multiple lesions during radiation therapy and chemotherapy in patients with gliomas Ali Choucair, Victor A. Levin, Philip H. Gutin, Journal of neurosurgery Pediatric Brain TumorsMultiple Cns LesionsHigh-grade GliomasBrain LesionGlioma	1986	260
RTOG 0211: A Phase 1/2 Study of Radiation Therapy With Concurrent Gefitinib for Newly Diagnosed Glioblastoma Patients Arnab Chakravarti, Meihua Wang, H. Ian Robins, International Journal of Radiation OncologyBiologyPhysics Neuro-oncologyRadiation MedicineRadiation TherapyMedicineConcurrent Gefitinib	2012	167
Net Clinical Benefit Analysis of Radiation Therapy Oncology Group 0525: A Phase III Trial Comparing Conventional Adjuvant Temozolomide With Dose-Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma Terri S. Armstrong, Jeffrey S. Wefel, Meihua Wang, Journal of Clinical Oncology	2013	136
Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas. Victor A. Levin, Kenneth R. Hess, Ali Choucair, PubMed	2003	114
A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023 Robert M. Cardinale, Minhee Won, Ali Choucair, International Journal of Radiation OncologyBiologyPhysics Neuro-oncologyPhase Ii TrialRadiation TherapyGliomaMedicine	2006	103
Risk of intracranial hemorrhage in glioma patients receiving anticoagulant therapy for venous thromboembolism Ali Choucair, Pamela Silver, Victor A. Levin Journal of neurosurgery High-grade GliomasGliomaSan FranciscoNeuro-oncologyThrombosis	1987	91
Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme. Victor A. Levin, Joon H. Uhm, Kurt A. Jaeckle, PubMed PharmacotherapyHigh-grade GliomasGliomaTumor BiologyNeuro-oncology	2000	89
Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma multiforme: RTOG protocol BR-00211 H. Ian Robins, Minhee Won, Wendy Seiferheld, Neuro-Oncology High-grade GliomasPkc-mediated SignalingGliomaTumor BiologyNeuro-oncology	2006	60
LKB1 regulates PRMT5 activity in breast cancer Hanine Lattouf, Loay Kassem, Julien Jacquemetton, International Journal of Cancer	2018	45

Page 1